MedWorm: Gene TherapyMedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest headlines from journals and sites in the Gene Therapy category.Encouraging gene therapy results in genetic form of blindness- September 9, 2008 NEW ROCHELLE, N.Y., September 08, 2008 PRNewswire -- All three patients who received intraocular adeno-associated virus-based gene therapy to treat Leber congenital amaurosis (LCA), an incurable genetic disorder that results in blindness, had... (Source: Drugs.com - Clinical Trials) MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.http://feeds.feedburner.com/~r/Drugscom-ClinicalTrials/~3/387695666/encouraging-gene-thera... Safety study indicates gene therapy for blindness improves vision- September 9, 2008 All three people who received gene therapy at the University of Florida to treat a rare, incurable form of blindness have regained some of their vision, according to a paper published online in Human Gene Therapy. (Source: Eye Health Optometry News From Medical News Today)http://www.medicalnewstoday.com/articles/120775.php Worms wiggle into gene therapy- September 9, 2008 Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. Gene therapy is a method of correcting faulty genes responsible for certain diseases, particularly cancers. It involves using a carrier, or 'vector', to insert new genetic material to mend a faulty gene in the affected cells of the person or 'host'. (Source:...http://www.medicalnewstoday.com/articles/120727.php Gene therapy for blindness improves vision, safety study indicates- September 9, 2008 No significant adverse effects were reported during a safety trial testing gene therapy on three patients with a type of hereditary blindness called Leber congenital amaurosis type 2. In addition, the subjects said the vision in their treated eyes was slightly improved in dim lighting conditions. (Source: ScienceDaily Headlines)http://feeds.sciencedaily.com/~r/sciencedaily/~3/387222794/080908185316.htm molecular imaging permanent coronary artery occlusion: cardiovascular mr imaging is platform for percutaneous transendocardial delivery and assessment- September 9, 2008 Purpose: To provide evidence that vascular endothelial growth factor (VEGF) genes delivered transendocardially with magnetic resonance (MR) imaging guidance may neovascularize or improve vascular recruitment in occlusive infarction. Materials and Methods: All experimental procedures received approval from the institutional committee on animal research. Dogs with permanent coronary artery occlusion were imaged twice (3 days after occlusion for assessment of acute infarction; a mean of 50 days...http://radiology.rsnajnls.org/cgi/content/short/2491072068v1?rss=1 Permanent coronary artery occlusion: cardiovascular mr imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy i- September 9, 2008 Related Articles Permanent Coronary Artery Occlusion: Cardiovascular MR Imaging Is Platform for Percutaneous Transendocardial Delivery and Assessment of Gene Therapy in Canine Model. Radiology. 2008 Sep 9; Authors: Saeed M, Martin A, Jacquier A, Bucknor M, Saloner D, Do L, Ursell P, Su H, Kan YW, Higgins CB Purpose: To provide evidence that vascular endothelial growth factor (VEGF) genes delivered transendocardially with magnetic resonance (MR) imaging guidance..http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Ret... Gene therapy prevents blindness in an animal model of mitochondrial dysfunction- September 9, 2008 Scientists have created an animal model suitable for testing and validating gene therapies for treatment of a common mitochondrial dysfunction that causes loss of vision. (Source: ScienceDaily Headlines)http://feeds.sciencedaily.com/~r/sciencedaily/~3/386759494/080904144825.htm Egg secretions from a worm may be useful in gene therapy- September 8, 2008 Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. (Source: News-Medical News Feed)http://www.news-medical.net/?id=41289 In an animal model of mitochondrial dysfunction, gene therapy prevents blindness- September 8, 2008 Scientists have created an animal model suitable for testing and validating gene therapies for treatment of a common mitochondrial dysfunction that causes loss of vision. The research, published by Cell Press in the September issue of the American Journal of Human Genetics, describes an innovation that represents a significant advance toward development of the first treatment for one of the many devastating disorders caused by mitochondrial disruption. (Source: Eye Health Optometry News From...http://www.medicalnewstoday.com/articles/120521.php Safety study indicates gene therapy for blindness improves vision- September 8, 2008 (University of Florida) No significant adverse effects were reported during a safety trial testing gene therapy on three patients with a type of hereditary blindness called Leber congenital amaurosis type 2. In addition, the subjects said the vision in their treated eyes was slightly improved in dim lighting conditions. The study was conducted by the University of Pennsylvania and the University of Florida with support from the National Eye Institute. (Source: EurekAlert! - Biology)http://www.eurekalert.org/pub_releases/2008-09/uof-ssi090808.php |